These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 25884643)

  • 21. Circulating Metastasis Associated in Colon Cancer 1 transcripts in gastric cancer patient plasma as diagnostic and prognostic biomarker.
    Burock S; Herrmann P; Wendler I; Niederstrasser M; Wernecke KD; Stein U
    World J Gastroenterol; 2015 Jan; 21(1):333-41. PubMed ID: 25574109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MACC1 is post-transcriptionally regulated by miR-218 in colorectal cancer.
    Ilm K; Fuchs S; Mudduluru G; Stein U
    Oncotarget; 2016 Aug; 7(33):53443-53458. PubMed ID: 27462788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Geographic analysis of RKIP expression and its clinical relevance in colorectal cancer.
    Koelzer VH; Karamitopoulou E; Dawson H; Kondi-Pafiti A; Zlobec I; Lugli A
    Br J Cancer; 2013 May; 108(10):2088-96. PubMed ID: 23632477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation.
    Lee S; Cho NY; Choi M; Yoo EJ; Kim JH; Kang GH
    Pathol Int; 2008 Feb; 58(2):104-13. PubMed ID: 18199160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the correlation of vasculogenic mimicry, ALDH1, KiSS-1, and MACC1 in the prediction of metastasis and prognosis in ovarian carcinoma.
    Yu L; Zhu B; Wu S; Zhou L; Song W; Gong X; Wang D
    Diagn Pathol; 2017 Mar; 12(1):23. PubMed ID: 28253891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic significance of p63 cytoplasmic expression in colorectal cancer. An immunohistochemical study.
    Albasri AM; Elkablawy MA; Ansari IA; Alhujaily AS; Khalil AA
    Saudi Med J; 2019 May; 40(5):432-439. PubMed ID: 31056618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating MACC1 transcripts in colorectal cancer patient plasma predict metastasis and prognosis.
    Stein U; Burock S; Herrmann P; Wendler I; Niederstrasser M; Wernecke KD; Schlag PM
    PLoS One; 2012; 7(11):e49249. PubMed ID: 23166620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased MACC1 expression indicates a poor prognosis independent of MET expression in gastric adenocarcinoma.
    Koh YW; Hur H; Lee D
    Pathol Res Pract; 2016 Feb; 212(2):93-100. PubMed ID: 26719224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of MACC1/c-Myc Expression in Endometrial Carcinoma with Clinical/Pathological Features or Prognosis.
    Zhang Q; Xu P; Lu Y; Dou H
    Med Sci Monit; 2018 Jul; 24():4738-4744. PubMed ID: 29984790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The apoptotic and proliferation rate of tumour budding cells in colorectal cancer outlines a heterogeneous population of cells with various impacts on clinical outcome.
    Dawson H; Koelzer VH; Karamitopoulou E; Economou M; Hammer C; Muller DE; Lugli A; Zlobec I
    Histopathology; 2014 Mar; 64(4):577-84. PubMed ID: 24111856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MACC1 upregulation promotes gastric cancer tumor cell metastasis and predicts a poor prognosis.
    Xie QP; Xiang C; Wang G; Lei KF; Wang Y
    J Zhejiang Univ Sci B; 2016 May; 17(5):361-6. PubMed ID: 27143263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MACC1 - a novel target for solid cancers.
    Stein U
    Expert Opin Ther Targets; 2013 Sep; 17(9):1039-52. PubMed ID: 23815185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages.
    Li W; Qiu T; Zhi W; Shi S; Zou S; Ling Y; Shan L; Ying J; Lu N
    BMC Cancer; 2015 May; 15():340. PubMed ID: 25929517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coexistence of MACC1 and NM23-H1 dysregulation and tumor budding promise early prognostic evidence for recurrence risk of early-stage colon cancer.
    Ozturk E; Aksoy SA; Ugras N; Tunca B; Ceylan S; Tezcan G; Yilmazlar T; Yerci O; Egeli U; Cecener G
    APMIS; 2018 Feb; 126(2):99-108. PubMed ID: 29700912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of plasma MACC1 levels on the prognostic stratification in patients with colorectal cancer.
    Lin A; Zhang RL; Zhang X; He XF; Zhang JG; Yan WH
    J Cell Mol Med; 2019 Feb; 23(2):1598-1601. PubMed ID: 30370603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.
    Kevans D; Wang LM; Sheahan K; Hyland J; O'Donoghue D; Mulcahy H; O'Sullivan J
    Int J Surg Pathol; 2011 Dec; 19(6):751-60. PubMed ID: 21791486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the correlation of MACC1, CD44, Twist1, and KiSS-1 in the metastasis and prognosis for colon carcinoma.
    Zhu B; Wang Y; Wang X; Wu S; Zhou L; Gong X; Song W; Wang D
    Diagn Pathol; 2018 Jul; 13(1):45. PubMed ID: 30021598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis.
    Zlobec I; Bihl MP; Schwarb H; Terracciano L; Lugli A
    Int J Cancer; 2010 Jul; 127(2):367-80. PubMed ID: 19908233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
    Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I
    Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of CDX2/CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype, and adverse prognosis in microsatellite-unstable colorectal cancer.
    Kim JH; Rhee YY; Bae JM; Cho NY; Kang GH
    Am J Surg Pathol; 2013 Oct; 37(10):1532-41. PubMed ID: 24025523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.